Resultados de la búsqueda 221-230 of 2662 for Assay
Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...
... assay. A database of paired clinical and sequencing data will also be established for future research. Study of Breast Cancer Risk Assessment in Female ...
Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. A Phase I/II, open-label, multi-center ...
Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. Numeración de páginas Estudios ...
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...
The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?